Todd Alfred Carter, Chief Scientific Officer at Voyager Therapeutics, Inc. (VYGR), sold 1,266 shares at $7.18 ($9K) on 2024-01-17, disclosed to the SEC on 2024-01-19.
Open-market sale of $9k VYGR by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| VYGR | SELL | 2026-02-11 | $14K | — | Filing → |
| VYGR | SELL | 2025-02-24 | $14K | — | Filing → |
| VYGR | SELL | 2025-02-12 | $24K | — | Filing → |